Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HCA HealthcareHCA -1.71%87 EV-to-EBIT is 11.62 as of Aug. 15, 2026, which is 1% above its 10-year median of 11.54. GuruFocus rates HCA with a GF Score™ of 87/100 and a GF Value™ of $457.95 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 472 Healthcare Providers & Services companies, HCA Healthcare ranks better than 66.31% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
HCA Healthcare's Enterprise Value for the quarter that ended in Jun. 2026 was $138,954 Mil.
HCA Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12,187 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HCA Healthcare EV-to-EBIT Related Terms
HCA Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for HCA Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, HCA Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCA Healthcare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HCA Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where HCA Healthcare's EV-to-EBIT falls into.
HCA Healthcare's current Enterprise Value is $141,586 Mil.
HCA Healthcare's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $12,187 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HCA Healthcare (HCA) has a EV-to-EBIT of 11.62 as of Aug. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on HCA Healthcare and its competitors. This is near median its historical median of 11.54. Over the past decade, HCA Healthcare's EV-to-EBIT has ranged from 8.24 to 14.66. According to the industry distribution chart, HCA Healthcare ranks #159 out of 472 companies in the Healthcare Providers & Services industry, placing it in the top 33.7%.
Is HCA Healthcare's EV-to-EBIT too high?
HCA Healthcare's current EV-to-EBIT of 11.62 is near median its 10-year median of 11.54. Over the past 10 years, this metric has ranged from a low of 8.24 to a high of 14.66. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. HCA Healthcare's value of 11.62 is 26.1% below this industry median. Based on the distribution chart, HCA Healthcare ranks #159 out of 472 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, HCA Healthcare has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HCA Healthcare's EV-to-EBIT compare to THC and DVA?
According to the Healthcare Providers & Services industry distribution chart, HCA Healthcare ranks #159 out of 472 companies for EV-to-EBIT. This puts HCA Healthcare in the upper half of its industry. The industry median EV-to-EBIT is 15.72. HCA Healthcare's value of 11.62 is 26.1% below this benchmark. Historically, HCA Healthcare's own EV-to-EBIT has ranged from 8.24 to 14.66 over the past decade. While the company's 10-year median is 11.54 vs. the industry median of 15.72, HCA Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 472 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCA Healthcare's current EV-to-EBIT of 11.62 is 26.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on HCA Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCA Healthcare's current EV-to-EBIT is 11.62, which is near median its own 10-year median of 11.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCA Healthcare stock overvalued right now?
Based on GuruFocus' analysis, HCA Healthcare (HCA) is currently considered Modestly Undervalued. The stock's GF Value™ is $457.95, compared to a current price of $404.68 — trading 11.6% below its estimated fair value. The current EV-to-EBIT is 11.62, which is near median its 10-year median of 11.54 and 26.1% below the Healthcare Providers & Services industry median of 15.72. HCA Healthcare's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For HCA Healthcare (HCA), the current EV-to-EBIT is 11.62 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HCA Healthcare (HCA) Overvalued in 2026?
Based on GuruFocus' analysis, HCA Healthcare stock appears to be undervalued.
The current stock price of $404.68 is trading 11.6% below its estimated GF Value™ of $457.95.
GuruFocus considers HCA Healthcare to be Modestly Undervalued.
Key valuation signals for HCA:
EV-to-EBIT: 11.62 (near median its 10-year median of 11.54)
GF Value™: $457.95 vs. price of $404.68 (11.6% below fair value)
Industry Position: 26.1% below the Healthcare Providers & Services median (#159 of 472)
No single metric tells the full story. See the HCA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
87GF Score
Get the complete analysis for HCA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCA has been successfully added to your 
